Lumens Bios

At a glance

Lumens Bios filed 66 disclosures in the last 12 months, including 6 5% holder, 3 insider and 3 issuance. The most recent key filing was on Oct 21: Conversion price ₩1,142; if all converted, equal to 37.9% of shares outstanding.

Revenue for 2025 was ₩176B, up 0.8% on 2024. It made an operating loss of ₩5B. Debt was 47% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩72.9B and operating loss of ₩886.6M.

The 2025 annual report lists 92 employees with an average tenure of 8.4 years and average pay of ₩65.3M, #887 of 2,191 listed companies by average pay. Its 5 directors and auditors were paid ₩47M each on average. It paid no cash dividend for 2025. (주)디티씨 and related parties held 22.30% at year end.

Of 5 recent 5%+ holder reports, 2 raised and 1 cut a stake; the largest stake reported was 27.36% on Sep 22.

From the 2025 annual report

Staff: 92 (74 men, 18 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩6B. Directors and auditors: 5, paid ₩235M in total.

No cash dividend was paid for 2025.

Largest shareholder

(주)디티씨 holds 21.97%; with 1 related party the group holds 22.30% of common shares at year end (from 3.08% at the start of the year).

Auditor: 삼덕회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports